COA of Formula: C8H18O3. In 2019.0 J ENZYM INHIB MED CH published article about GROWTH-FACTOR RECEPTOR; NATIONAL-CANCER-INSTITUTE; DRUG DISCOVERY; BREAST-CANCER; IN-VITRO; EXPRESSION; SURVIVAL; THERAPY; ASSAY in [Maher, Mai; Kassab, Asmaa E.; Zaher, Ashraf F.; Mahmoud, Zeinab] Cairo Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Cairo 11562, Egypt in 2019.0, Cited 36.0. The Name is 1,1,1-Triethoxyethane. Through research, I have a further understanding and discovery of 78-39-7.
A series of novel pyrazolo[3,4-d]pyrimidines was synthesised. Twelve synthesised compounds were evaluated for their anticancer activity against 60 human tumour cell lines by NCI (USA). Compound 7d proved prominent anticancer activity. It showed 1.6-fold more potent anti-proliferative activity against OVCAR-4 cell line with IC50 = 1.74 mu M. It also exhibited promising potent anticancer activity against ACHN cell line with IC50 value 5.53 mu M, representing 2.2-fold more potency than Erlotinib. Regarding NCI-H460 cell line, compound 7d (IC50 = 4.44 mu M) was 1.9-fold more potent than Erlotinib. It inhibited EGFR and ErbB2 kinases at sub-micromolar level (IC50 = 0.18 and 0.25 mu M, respectively). Dual inhibition of EGFR and ErbB2 caused induction of apoptosis which was confirmed by a significant increase in the level of active caspase-3 (11-fold). It showed accumulation of cells in pre-G1 phase and cell cycle arrest at G2/M phase.
COA of Formula: C8H18O3. Welcome to talk about 78-39-7, If you have any questions, you can contact Maher, M; Kassab, AE; Zaher, AF; Mahmoud, Z or send Email.
Reference:
Thiazolidine – Wikipedia,
,Thiazolidine – ScienceDirect.com